Predictive nomograms for risk and prognostic factors in metastatic bladder cancer: a population-based study

被引:2
作者
Shi, Shuibo [1 ]
Peng, Guangbei [2 ]
Luo, Longhua [1 ]
Li, Dongshui [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 1, Dept Urol, Yongwai St 17, Nanchang 330209, Peoples R China
[2] Childrens Med Ctr Jiangxi Prov, Nanchang, Peoples R China
关键词
Metastatic bladder cancer (MBC); risk; prognosis; nomograms; Surveillance Epidemiology and End Results database (SEER database); CARCINOMA;
D O I
10.21037/tcr-23-1229
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Given the poor prognosis of patients with metastatic bladder cancer (MBC), the development of an effective diagnostic and prognostic model is significant in cancer management and for guidance in clinical practice.Methods: We acquired data of 23,180 bladder cancer patients from Surveillance Epidemiology and End Results (SEER) database registered from 2010 to 2019. The optimal cut-off value for patient age and tumor size was determined by x-tile software. Independent risk factors for MBC were identified by univariate and multivariate logistic regression analyses and prognosis factors were identified by univariate and multivariate cox regression analyses, and risk and prognostic nomograms were constructed. The accuracy of the nomograms was verified by receiver operating characteristic (ROC) curves, calibration curves, and its clinical utility was determined by decision curve analysis (DCA) curves and clinical impact curves (CIC). Kaplan Meier (K-M) survival curves further confirmed the clinical validity of the prognostic model.Results: Through logistic regression analyses, we derived that age, histological type, tumor size, T stage, and N stage were independent risk factors for metastasis in bladder cancer patients. By cox regression analyses, age, chemotherapy, histological type, bone, lung and liver metastases were identified as risk factors influencing prognosis of MBC patients. Area under the curve (AUC) of the risk nomogram was 0.80, the AUC values of 1/2/3 years were 0.74/0.71/0.71 in the training group and 0.81/0.77/0.77 in the validation group. Based on calibration curves, DCA curves, CIC and K-M curves, the nomograms were validated with excellent predictive performance and clinical utility for MBC.Conclusions: The nomograms we constructed have perfect predictive accuracy and clinical practicality for MBC patients, enabling clinicians to provide treatment advice and clinical guidance to patients.
引用
收藏
页码:3284 / 3302
页数:19
相关论文
共 32 条
[1]   Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence [J].
Barone, Biagio ;
Finati, Marco ;
Cinelli, Francesco ;
Fanelli, Antonio ;
Del Giudice, Francesco ;
De Berardinis, Ettore ;
Sciarra, Alessandro ;
Russo, Gianluca ;
Mancini, Vito ;
D'Altilia, Nicola ;
Ferro, Matteo ;
Porreca, Angelo ;
Chung, Benjamin I. ;
Basran, Satvir ;
Bettocchi, Carlo ;
Cormio, Luigi ;
Imbimbo, Ciro ;
Carrieri, Giuseppe ;
Crocetto, Felice ;
Busetto, Gian Maria .
JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (03)
[2]   Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma [J].
Bellmunt, J. ;
de Wit, R. ;
Vaughn, D. J. ;
Fradet, Y. ;
Lee, J. -L. ;
Fong, L. ;
Vogelzang, N. J. ;
Climent, M. A. ;
Petrylak, D. P. ;
Choueiri, T. K. ;
Necchi, A. ;
Gerritsen, W. ;
Gurney, H. ;
Quinn, D. I. ;
Culine, S. ;
Sternberg, C. N. ;
Mai, Y. ;
Poehlein, C. H. ;
Perini, R. F. ;
Bajorin, D. F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11) :1015-1026
[3]   New Therapeutic Challenges in Advanced Bladder Cancer [J].
Bellmunt, Joaquim ;
Petrylak, Daniel P. .
SEMINARS IN ONCOLOGY, 2012, 39 (05) :598-607
[4]   Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract [J].
Bellmunt, Joaquim ;
Theodore, Christine ;
Demkov, Tomasz ;
Komyakov, Boris ;
Sengelov, Lisa ;
Daugaard, Gedske ;
Caty, Armelle ;
Carles, Joan ;
Jagiello-Gruszfeld, Agnieszka ;
Karyakin, Oleg ;
Delgado, Francois-Michel ;
Hurteloup, Patrick ;
Morsli, Nassim ;
Salhi, Yacine ;
Culine, Stephane ;
von der Maase, Hans .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) :4454-4461
[5]   Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data [J].
Bono, AV ;
Goebell, PJ ;
Groshen, S ;
Lehmann, J ;
Studer, U ;
Torti, FM ;
Abol-Enein, H ;
Bassi, P ;
Boyer, M ;
Coppin, CML ;
Cortesi, E ;
Hall, RR ;
Horwich, A ;
Malmström, PU ;
Martínez-Piñeiro, JA ;
Sengelov, L ;
Sherif, A ;
Wallace, DMA ;
Clarke, NW ;
Roberts, JT ;
Sylvester, R ;
Parmar, MKB ;
Stewart, LA ;
Tierney, JF ;
Vale, CL .
EUROPEAN UROLOGY, 2005, 48 (02) :189-201
[6]   PET/CT in Bladder Cancer: An Update [J].
Bouchelouche, Kirsten .
SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (04) :475-485
[7]   The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma [J].
Cathomas, Richard ;
Lorch, Anja ;
Bruins, Harman M. ;
Comperat, Eva M. ;
Cowan, Nigel C. ;
Efstathiou, Jason A. ;
Fietkau, Rainer ;
Gakis, Georgios ;
Hernandez, Virginia ;
Espinos, Estefania Linares ;
Neuzillet, Yann ;
Ribal, Maria J. ;
Rouanne, Matthieu ;
Thalmann, George N. ;
van der Heijden, Antoine G. ;
Veskimae, Erik ;
Witjes, J. Alfred ;
Milowsky, Matthew I. .
EUROPEAN UROLOGY, 2022, 81 (01) :95-103
[8]   The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks [J].
Cumberbatch, Marcus G. ;
Rota, Matteo ;
Catto, James W. F. ;
La Vecchia, Carlo .
EUROPEAN UROLOGY, 2016, 70 (03) :458-466
[9]   Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database [J].
Del Bene, Gabriella ;
Calabro, Fabio ;
Giannarelli, Diana ;
Plimack, Elizabeth R. ;
Harshman, Lauren C. ;
Yu, Evan Y. ;
Crabb, Simon J. ;
Pal, Sumanta Kumar ;
Alva, Ajjai S. ;
Powles, Thomas ;
De Giorgi, Ugo ;
Agarwal, Neeraj ;
Bamias, Aristotelis ;
Ladoire, Sylvain ;
Necchi, Andrea ;
Vaishampayan, Ulka N. ;
Niegisch, Gunter ;
Bellmunt, Joaquim ;
Baniel, Jack ;
Galsky, Matthew D. ;
Sternberg, Cora N. .
FRONTIERS IN ONCOLOGY, 2018, 8
[10]   Bladder Cancer: Current Challenges and Future Directions [J].
Dobruch, Jakub ;
Oszczudlowski, Maciej .
MEDICINA-LITHUANIA, 2021, 57 (08)